SONX · Sonendo, Inc.
$0.55
At close · Aug 14
Going-concern doubt
— flagged Mar 26, 2025
Substantial doubt about the company's ability to continue as a going concern.
“There is a material uncertainty that raise substantial doubt about our ability to continue as a going concern and, therefore, that we may be unable to realize our assets and discharge our liabilities in the normal course of business.”View the 10-K filed Mar 26, 2025
Market Cap
$235,071
Shares
427,401
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$33.2M
-24.3%
FY2024
Net Income
-$28.03M
+54%
FY2024
Gross Margin
35.67%
+25pp
FY2024
Operating Margin
-88.45%
+46.7pp
FY2024
Diluted EPS
-$59.03
+54.5%
FY2024
Operating Cash Flow
-$24.65M
+46.5%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| — | $33.2M | $43.87M | $41.66M | $33.2M | $23.35M | |
| — | $19.86M | $29.96M | $31.18M | $24.86M | $19.47M | |
| — | $11.84M | $4.67M | $10.48M | $8.34M | $3.89M | |
| — | 35.67% | 10.64% | 25.16% | 25.11% | 16.64% | |
| — | $6.76M | $10.44M | $16.78M | $18.57M | $20.46M | |
| — | $17.1M | $28.7M | — | — | — | |
| — | $17.35M | $24.79M | — | — | — | |
| $49.97M | — | $54.02M | $51.91M | $33.91M | $26.7M | |
| — | $51K | $585K | $664K | $586K | $531K | |
| — | $41.21M | $63.93M | $68.68M | $52.74M | $46.68M | |
| — | -$29.37M | -$59.27M | -$58.2M | -$44.41M | -$42.8M | |
| — | -88.45% | -135.11% | -139.72% | -133.77% | -183.28% | |
| — | $5.47M | $6.46M | — | — | — | |
| — | -$4.17M | -$3.2M | — | — | — | |
| — | -$33.54M | -$62.46M | -$57.05M | -$48.5M | -$46.66M | |
| — | $2000 | $2000 | $2000 | $2000 | $2000 | |
| — | -$28.03M | -$60.92M | -$57.05M | -$48.5M | -$46.67M | |
| — | -84.44% | -138.88% | -136.96% | -146.09% | -199.84% | |
| — | -$28.04M | -$60.85M | -$57.11M | -$48.5M | — | |
| USD/shares | — | -$59.03 | -$129.63 | -$50,800.00 | -$340,800.00 | — |
| USD/shares | — | -$59.03 | -$129.63 | -$50,800.00 | -$340,800.00 | — |
| shares | — | 474.86K | 469.94K | 1123.3238 | 142.3649 | 29.8986 |
| shares | — | 474.86K | 469.94K | 1123.3238 | 142.3649 | 29.8986 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.62×
EV/EBIT
—
Medical Devices median 22.75×
P/E (TTM)
—
Medical Devices median 29.90×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Product | $31,702,000 | $34,628,000 | $33,280,000 | $25,811,000 | $17,338,000 |
| Software | — | — | $8,376,000 | $7,386,000 | $6,013,000 |